Literature DB >> 2583055

Location of the second steroid-binding site on the glucocorticoid receptor.

F Svec1, V Teubner, D Tate.   

Abstract

The ability of nonradioactive progesterone to accelerate the dissociation of tritiated dexamethasone from the agonist-binding site of the glucocorticoid receptor was used as a probe for the existence of a second antagonist steroid site. The goal was to evaluate if this second site was on the glucocorticoid receptor and, if so, on what region of that protein. The magnitude of acceleration of dissociation was assessed during purification of the receptor as well as with the untransformed (multimeric), transformed (monomeric), and mero-receptor. In each preparation progesterone caused a statistically significant increase in the rate of agonist dissociation. The documentation of acceleration of dissociation during purification suggests that progesterone one is interacting with a site on the glucocorticoid receptor and not with another protein. Evidence for the second binding site was found using each form of the receptor, untransformed, transformed, and mero-receptor, suggesting that the second binding site resides on the steroid-binding domain of the receptor which is on the carboxy-terminus, topographically close to the agonist-binding site.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583055     DOI: 10.1210/endo-125-6-3103

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Aldosterone antagonists destabilize the mineralocorticosteroid receptor.

Authors:  B Couette; M Lombes; E E Baulieu; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

2.  Glucocorticoids inhibit gonadotropin-releasing hormone by acting directly at the hypothalamic level.

Authors:  A E Calogero; N Burrello; A M Bosboom; M R Garofalo; R F Weber; R D'Agata
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

3.  Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor.

Authors:  Michael S Christodoulou; Federico Dapiaggi; Francesca Ghiringhelli; Stefano Pieraccini; Maurizio Sironi; Marianna Lucafò; Debora Curci; Giuliana Decorti; Gabriele Stocco; Chandra Sekhar Chirumamilla; Wim Vanden Berghe; Patrick Balaguer; Benoît Y Michel; Alain Burger; Egle M Beccalli; Daniele Passarella; Nadine Martinet
Journal:  ACS Med Chem Lett       Date:  2018-02-26       Impact factor: 4.345

4.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 5.  Influence of gonadal steroids on brain corticosteroid receptors: a minireview.

Authors:  B B Turner
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

6.  Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role.

Authors:  Rachael S Allen; Iqbal Sayeed; Yuliya Oumarbaeva; Katherine C Morrison; Paul H Choi; Machelle T Pardue; Donald G Stein
Journal:  Restor Neurol Neurosci       Date:  2016-11-22       Impact factor: 2.406

Review 7.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

8.  Crosstalk between monocytes and myometrial smooth muscle in culture generates synergistic pro-inflammatory cytokine production and enhances myocyte contraction, with effects opposed by progesterone.

Authors:  S P Rajagopal; J L Hutchinson; D A Dorward; A G Rossi; J E Norman
Journal:  Mol Hum Reprod       Date:  2015-05-22       Impact factor: 4.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.